Concord Biotech Ltd Financials Statements

Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

Consolidate
Standalone
Financial Year
Dec '23
Sep '23
Jun '23
Mar '23
Dec '22
Total Qtr Revenue cr
248.98
270.47
201.48
284.79
249.93
Other Income Qtr Cr8.198.136.6512.209.25
Operating Revenues Qtr240.80262.35194.83272.59240.68

*All values are in Cr.

Operating Expenses Qtr
134.87
143.16
122.68
143.52
129.00
Operating Profit Qtr
105.93
119.19
72.15
129.06
111.68
EBIDT Qtr Cr
114.12
127.32
78.81
141.26
120.93
Depreciation Qtr
13.54
13.30
13.04
14.18
13.77
Net Profit Qtr
77.57
81.02
54.49
91.49
77.37
Basic EPS Qtr
7.41
7.74
5.21
8.75
7.40
Open Demat Account
or Resume your Application
+91 -

personImage